Inulin oligofructose attenuates metabolic syndrome in high-carbohydrate, high-fat diet-fed rats

British Journal of Nutrition

Volumn 116, Issue 9, 2016, Pages 1502-1511

  Kumar, Senthil A ^a   Ward, Leigh C ^b   Brown, Lindsay ^a  

^a UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Inulin; Metabolic syndrome; Oligofructose; Prebiotics; Rats

Indexed keywords

ALANINE AMINOTRANSFERASE; FAT DROPLET; FATTY ACID; FRUCTOSE OLIGOSACCHARIDE; GLUCOSE; INSULIN; INULIN; INULIN OLIGOFRUCTOSE; STARCH; UNCLASSIFIED DRUG; ANTIOBESITY AGENT; FRUCTOSE; NONSTEROID ANTIINFLAMMATORY AGENT; OLIGOSACCHARIDE; PREBIOTIC AGENT;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CECUM; CELL INFILTRATION; COLON; CONTROLLED STUDY; CRYPT CELL; DIET THERAPY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; ILEUM; INFLAMMATORY CELL; LIPID DIET; LIPID TRANSPORT; MALE; METABOLIC SYNDROME X; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; CARBOHYDRATE LOADING DIET; DISEASE MODEL; IMMUNOLOGY; INTESTINE MUCOSA; LIVER; METABOLISM; OBESITY; ORGAN SIZE; PATHOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-OBESITY AGENTS; CECUM; COLON; DIET, CARBOHYDRATE LOADING; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FRUCTOSE; ILEUM; INTESTINAL MUCOSA; INULIN; LIVER; MALE; METABOLIC SYNDROME X; OBESITY; OLIGOSACCHARIDES; ORGAN SIZE; PREBIOTICS; RANDOM ALLOCATION; RATS, WISTAR; WEIGHT GAIN;

EID: 84994092920     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114516003627     Document Type: Article

References (73)

1. Granado-Lorencio F & Hernández-Alvarez E (2016) Functional foods and health effects: a nutritional biochemistry perspective. Curr Med Chem (epublication ahead of print version 14 June 2016).
2. Brown L, Poudyal H & Panchal SK (2015) Functional foods as potential therapeutic options for metabolic syndrome. Obes Rev 16, 914-941.
3. Leach JD & Sobolik KD (2010) High dietary intake of prebiotic inulin-type fructans in the prehistoric Chihuahuan Desert. Br J Nutr 103, 1558-1561.
4. Florowska A, Krygier K, Florowski T, et al. (2016) Prebiotics as functional food ingredients preventing diet-related diseases. Food Funct 18, 2147-2155.
5. Jones JM (2014) CODEX-aligned dietary fiber definitions help to bridge the 'fiber gap'. Nutr J 13, 34.
6. Bonnema AL, Kolberg LW, Thomas W, et al. (2010) Gastrointestinal tolerance of chicory inulin products. J Am Diet Assoc 110, 865-868.
7. Mensink MA, Frijlink HW, van der Voort Maarschalk K, et al. (2015) Inulin, a flexible oligosaccharide II: review of its pharmaceutical applications. Carbohydr Polym 134, 418-428.
8. Mensink MA, Frijlink HW, van der Voort Maarschalk K, et al. (2015) Inulin, a flexible oligosaccharide I: review of its physicochemical characteristics. Carbohydr Polym 130, 405-419.
9. Niness KR (1999) Inulin and oligofructose: what are they? J Nutr 129, Suppl. 7, 1402S-1406S.
10. Maurer AD, Eller LK, Hallam MC, et al. (2010) Consumption of diets high in prebiotic fiber or protein during growth influences the response to a high fat and sucrose diet in adulthood in rats. Nutr Metab (Lond) 7, 77.
11. Cani PD, Dewever C & Delzenne NM (2004) Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 92, 521-526.
12. Cani PD, Neyrinck AM, Maton N, et al. (2005) Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes Res 13, 1000-1007.
13. Beylot M (2005) Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 93, Suppl. 1, S163-S168.
14. Panchal SK, Poudyal H, Iyer A, et al. (2011) High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol 57, 611-624.
15. Coudray C, Tressol JC, Gueux E, et al. (2003) Effects of inulintype fructans of different chain length and type of branching on intestinal absorption and balance of calcium and magnesium in rats. Eur J Nutr 42, 91-98.
16. Roberfroid MB (2007) Inulin-type fructans: functional food ingredients. J Nutr 137, 2493S-2502S.
17. Poudyal H, Panchal S & Brown L (2010) Comparison of purple carrot juice and beta-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br J Nutr 104, 1322-1332.
18. Poudyal H, Panchal SK, Ward LC, et al. (2013) Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. J Nutr Biochem 24, 1041-1052.
19. de Simone G, di Lorenzo L, Costantino G, et al. (1988) Echocardiographic indexes of left ventricular contractility. Effect of load manipulation in arterial hypertension. Jpn Heart J 29, 151-160.
20. Kumar SA, Magnusson M, Ward LC, et al. (2015) Seaweed supplements normalise metabolic, cardiovascular and liver responses in high-carbohydrate, high-fat fed rats. Mar Drugs 13, 788-805.
21. Delmée E, Cani PD, Gual G, et al. (2006) Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci 79, 1007-1013.
22. Adam CL, Williams PA, Garden KE, et al. (2015) Dosedependent effects of a soluble dietary fibre (pectin) on food intake, adiposity, gut hypertrophy and gut satiety hormone secretion in rats. PLOS ONE 10, e0115438.
23. Folch J, Lees M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
24. Poudyal H, Panchal SK, Waanders J, et al. (2012) Lipid redistribution by alpha-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats. J Nutr Biochem 23, 153-162.
25. Sagher FA, Dodge JA, Johnston CF, et al. (1991) Rat small intestinal morphology and tissue regulatory peptides: effects of high dietary fat. Br J Nutr 65, 21-28.
26. Kerem M, Salman B, Pasaoglu H, et al. (2008) Effects of microalgae Chlorella species crude extracts on intestinal adaptation in experimental short bowel syndrome. World J Gastroenterol 14, 4512-4517.
27. Roberfroid M (1993) Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects. Crit Rev Food Sci Nutr 33, 103-148.
28. Jacobsen R, Lorenzen JK, Toubro S, et al. (2005) Effect of short-term high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion. Int J Obes (Lond) 29, 292-301.
29. Friedrich M, Petzke KJ, Raederstorff D, et al. (2012) Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a highfat diet. Int J Obes (Lond) 36, 735-743.
30. Shin AC, Zheng H, Townsend RL, et al. (2013) Longitudinal assessment of food intake, fecal energy loss, and energy expenditure after Roux-en-Y gastric bypass surgery in highfat- fed obese rats. Obes Surg 23, 531-540.
31. Westerterp KR, Smeets A, Lejeune MP, et al. (2008) Dietary fat oxidation as a function of body fat. Am J Clin Nutr 87, 132-135.
32. Delzenne NM, Cani PD & Neyrinck AM (2007) Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr 137, 2547S-2551S.
33. Parnell JA & Reimer RA (2012) Prebiotic fibres dosedependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. Br J Nutr 107, 601-613.
34. Verhoef SP, Meyer D & Westerterp KR (2011) Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake. Br J Nutr 106, 1757-1762.
35. Chaudhri OB, Salem V, Murphy KG, et al. (2008) Gastrointestinal satiety signals. Annu Rev Physiol 70, 239-255.
36. Slavin J (2013) Fiber and prebiotics: mechanisms and health benefits. Nutrients 5, 1417-1435.
37. Kaur N & Gupta AK (2002) Applications of inulin and oligofructose in health and nutrition. J Biosci 27, 703-714.
38. Akalin AS & Erisir D (2008) Effects of inulin and oligofructose on the rheological characteristics and probiotic culture survival in low-fat probiotic ice cream. J Food Sci 73, M184-M188.
39. Little TJ, Horowitz M & Feinle-Bisset C (2007) Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity. Am J Clin Nutr 86, 531-541.
40. Park JH, Kwon OD, Ahn SH, et al. (2013) Fatty diets retarded the propulsive function of and attenuated motility in the gastrointestinal tract of rats. Nutr Res 33, 228-234.
41. Roberfroid MB & Delzenne NM (1998) Dietary fructans. Annu Rev Nutr 18, 117-143.
42. Lobo AR, Filho JM, Alvares EP, et al. (2009) Effects of dietary lipid composition and inulin-type fructans on mineral bioavailability in growing rats. Nutrition 25, 216-225.
43. Madden JA & Hunter JO (2002) A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 88, Suppl. 1, S67-S72.
44. Veereman G (2007) Pediatric applications of inulin and oligofructose. J Nutr 137, 2585S-2589S.
45. Zhang C, Yin A, Li H, et al. (2015) Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children. EBioMedicine 2, 966-982.
46. Brun P, Castagliuolo I, Di Leo V, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292, G518-G525.
47. Cani PD, Bibiloni R, Knauf C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481.
48. DiBaise JK, Frank DN & Mathur R (2012) Impact of the gut microbiota on the development of obesity: current concepts. Am J Gastroenterol Suppl 1, 22-27.
49. Ghanim H, Abuaysheh S, Sia CL, et al. (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32, 2281-2287.
50. Stenman LK, Waget A, Garret C, et al. (2014) Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Benef Microbes 5, 437-445.
51. Griffiths EA, Duffy LC, Schanbacher FL, et al. (2004) In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 49, 579-589.
52. Rodes L, Saha S, Tomaro-Duchesneau C, et al. (2014) Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. Biomed Res Int 2014, 602832.
53. Amar J, Chabo C, Waget A, et al. (2011) Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 3, 559-572.
54. Janssen P, Rotondo A, Mule F, et al. (2013) Review article: a comparison of glucagon-like peptides 1 and 2. Aliment Pharmacol Ther 37, 18-36.
55. Cani PD, Possemiers S, Van de Wiele T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103.
56. Nilsson A, Ostman E, Preston T, et al. (2008) Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. Eur J Clin Nutr 62, 712-720.
57. Luo J, Rizkalla SW, Alamowitch C, et al. (1996) Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr 63, 939-945.
58. Lee KU, Park JY, Kim CH, et al. (1996) Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats. Metabolism 45, 1408-1414.
59. Stanhope KL & Havel PJ (2008) Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 19, 16-24.
60. Weisberg SP, McCann D, Desai M, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
61. Damaso AR, do Prado WL, de Piano A, et al. (2008) Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Dig Liver Dis 40, 132-139.
62. Fabbrini E, Sullivan S & Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51, 679-689.
63. Hietbrink F, Besselink MG, Renooij W, et al. (2009) Systemic inflammation increases intestinal permeability during experimental human endotoxemia. Shock 32, 374-378.
64. Lau WL, Kalantar-Zadeh K & Vaziri ND (2015) The gut as a source of inflammation in chronic kidney disease. Nephron 130, 92-98.
65. Huang EY, Leone VA, Devkota S, et al. (2013) Composition of dietary fat source shapes gut microbiota architecture and alters host inflammatory mediators in mouse adipose tissue. JPEN J Parenter Enteral Nutr 37, 746-754.
66. Gregor MF & Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445.
67. Barbaro NR, Fontana V, Modolo R, et al. (2015) Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers. Blood Press 24, 7-13.
68. Pietri P, Vyssoulis G, Vlachopoulos C, et al. (2006) Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 24, 2231-2238.
69. Juskewitch JE, Knudsen BE, Platt JL, et al. (2012) LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels. Am J Pathol 180, 32-40.
70. Kararigas G, Dworatzek E, Petrov G, et al. (2014) Sex-dependent regulation of fibrosis and inflammation in human left ventricular remodelling under pressure overload. Eur J Heart Fail 16, 1160-1167.
71. Nicoletti A & Michel JB (1999) Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res 41, 532-543.
72. Dietitians Association of Australia (1983) For the public: Smart Eating for you: Nutrition Information A-Z: Fibre. http://daa.asn.au/?-page-id=800.
73. Reagan-Shaw S, Nihal M & Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22, 659-661.